James Wooldridge - 04 Mar 2021 Form 4 Insider Report for Checkmate Pharmaceuticals, Inc.

Role
Chief Medical Officer
Signature
/s/ Kleem Chaudhary, attorney-in-fact
Issuer symbol
N/A
Transactions as of
04 Mar 2021
Net transactions value
$0
Form type
4
Filing time
28 Apr 2022, 17:03:37 UTC
Next filing
06 Aug 2021
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CMPI Stock Option (Right to Buy) Award $0 +54,600 $0.000000 54,600 04 Mar 2021 Common Stock 54,600 $13.50 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This stock option shall vest 25% on the first anniversary of the vesting start date of March 5, 2021 and in substantially equal monthly installments for a period of 36 months thereafter, subject to the Reporting Persons continued service through such date.